Jan Nyman
Overview
Explore the profile of Jan Nyman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1504
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wallmander C, Bosaeus I, Silander E, Berg M, Cange H, Nyman J, et al.
Clin Nutr ESPEN
. 2025 Feb;
66:332-342.
PMID: 39892786
Background & Aims: Head and neck cancer (HNC) involves several tumor locations, the most common of which are the oropharynx and oral cavity. Patients with HNC are at high risk...
2.
Gunnarsson K, Movik L, Pettersson N, Back A, Nyman J, Hallqvist A
Acta Oncol
. 2024 Oct;
63:791-797.
PMID: 39415565
Purpose: Radiation pneumonitis (RP) is a dose-limiting toxicity associated with increased mortality for patients with non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT). This study aims to assess the...
3.
Berg M, Hansson C, Silander E, Bove M, Johansson L, Cange H, et al.
Head Neck
. 2024 Jan;
46(4):760-771.
PMID: 38192119
Background: Head and neck cancer (HNC) patients have a high risk of developing malnutrition. This randomized study aimed to compare the effect of weekly cisplatin or cetuximab combined with radiotherapy...
4.
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindback E, Jirf K, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jul;
117(5):1222-1231.
PMID: 37423292
Purpose: Stereotactic body radiation therapy for tumors near the central airways implies high-grade toxic effects, as concluded from the HILUS trial. However, the small sample size and relatively few events...
5.
Berg M, Silander E, Bove M, Johansson L, Nyman J, Hammerlid E
Laryngoscope
. 2023 Jan;
133(9):2211-2221.
PMID: 36695154
Objectives: Fatigue due to cancer is a challenging symptom that might be long-lasting after cancer treatment. The aim of this study was to follow the development of fatigue among head...
6.
Bratulic S, Limeta A, Dabestani S, Birgisson H, Enblad G, Stalberg K, et al.
Proc Natl Acad Sci U S A
. 2022 Dec;
119(50):e2115328119.
PMID: 36469776
Cancer mortality is exacerbated by late-stage diagnosis. Liquid biopsies based on genomic biomarkers can noninvasively diagnose cancers. However, validation studies have reported ~10% sensitivity to detect stage I cancer in...
7.
Fesse P, Nyman J, Hermansson I, Book M, Ahlgren J, Turesson I
iScience
. 2022 Oct;
25(10):105238.
PMID: 36274944
DNA-damage response of cutaneous interfollicular melanocytes to fractionated radiotherapy was investigated by immunostaining of tissue sections from punch biopsies collected before, during, and after the treatment of patients for breast...
8.
Sarudis S, Karlsson A, Nyman J, Back A
Acta Oncol
. 2022 Jul;
61(8):1004-1011.
PMID: 35905048
Background: Respiratory-induced lung tumor motion may affect the delivered dose in stereotactic body radiation therapy (SBRT). Previous studies are often based on phantom studies for one specific treatment technique. In...
9.
Abel E, Silander E, Nordstrom F, Olsson C, Brodin N, Nyman J, et al.
Adv Radiat Oncol
. 2022 Jul;
7(5):100960.
PMID: 35847551
Purpose: Although fatigue is a known side effect in patients with head and neck cancer (HNC) receiving radiation therapy, knowledge regarding long-term fatigue and dose-response relationships to organs at risk...
10.
Eklund E, Wiel C, Fagman H, Akyurek L, Raghavan S, Nyman J, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565194
There is an urgent need to identify new predictive biomarkers for treatment response to both platinum doublet chemotherapy (PT) and immune checkpoint blockade (ICB). Here, we evaluated whether treatment outcome...